关于临床上先进的PROTAC降解剂及其合成的最新情况
Ranjan Kumar Acharyya1, Yugandhar Kothapalli2, Suresh Yarlagadda3
1Rogel Cancer Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Molecules (Basel, Switzerland)
|January 10, 2026
概括
化向化体 (PROTACs) 提供了一种新的治疗方法,通过利用细胞的自然处置系统降解向蛋白质. 这篇综述强调了PROTACs的进展,临床开发和分子设计的进展到试验.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对蛋白质分解的嵌合体 (PROTACs) 代表了一种开创性的治疗策略.
- PROTACs利用无素-蛋白酶体系统 (UPS) 进行向的蛋白质降解.
- 与传统的抑制剂不同,PROTACs具有增强的特异性,可以向以前无法治疗的蛋白质.
研究的目的:
- 为了提供一个全面的PROTAC技术的审查.
- 详细介绍目前的PROTAC目标和临床发展.
- 检查临床上先进的PROTAC分子的设计和合成.
主要方法:
- 关于PROTAC研究和临床试验的文献综述.
- 对 PROTAC 设计原则和合成策略的分析.
- 目标蛋白降解 (TPD) 机制的概述.
主要成果:
- 在过去的20年中,PROTACs在TPD方面取得了重大进展.
- 几种PROTAC正在接近其首次临床批准.
- 该审查涵盖了PROTAC的具体目标及其临床进展.
结论:
- PROTAC是一种革命性的治疗方式,具有广泛的潜力.
- 该领域正在迅速向临床应用迈进.
- 了解PROTAC的设计和合成对于未来的药物开发至关重要.
相关概念视频
Prodrugs
4.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.0K
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
2.2K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
2.2K


